🔎 Trials Near Me

Akèy › Limfom selil mantèl › Ohio › Cleveland

Etid klinik pou Limfom selil mantèl nan Cleveland, OH

7 etid pou Limfom selil mantèl ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Ap rekriteFaz 3
  • University Hospitals, Cleveland
  • Cleveland Clinic Foundation, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

Ap rekriteFaz 2
  • Case Western Reserve University, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07003295

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Ap rekriteFaz 1
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07225439

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Ap rekriteFaz 1
  • University Hospitals Cleveland Medical Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05780034

Etid Limfom selil mantèl nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.